Glossary · Coding

CPT Category III

CPT Category III codes are temporary, alphanumeric tracking codes (formatted as four digits followed by the letter T, e.g., 0123T) assigned to emerging technologies, services, and procedures that have not yet met the full criteria required for a permanent Category I CPT code. They exist primarily to enable data collection that can support FDA approval pathways or demonstrate widespread clinical adoption.

Verified May 8, 2026 · 7 sources ↓

Drawn from AMAAAOSUrologytimesCMSAAPC

Definition

Source · Editorial summary grounded in 7 cited references ↓

CPT Category III codes occupy a distinct lane in the CPT code set. Unlike Category I codes—which require FDA clearance where applicable, demonstrated use by many clinicians across the country, and peer-reviewed evidence of clinical efficacy—Category III codes can be assigned when only one of several lower thresholds is met: an active study protocol, specialty society support, available U.S. peer-reviewed literature, or documented U.S. clinical trials. This deliberately low bar lets the coding system keep pace with innovation without prematurely endorsing unproven procedures.

The codes follow a five-character HIPAA-compliant format: four sequential numerals plus a trailing 'T' (e.g., 0456T). They are published in a dedicated section of the CPT manual, after Category II codes, rather than grouped by anatomical region or service type the way Category I codes are. The AMA CPT Editorial Panel releases new Category III codes on a semiannual schedule—January 1 and July 1—with a six-month runway before each batch becomes reportable. The complete set is also published in the annual CPT book.

Category III codes carry no AMA-assigned relative value units (RVUs) and are therefore excluded from the annual RUC valuation process. Payment, when it occurs at all, is determined entirely by individual payer policy or local Medicare contractor coverage decisions. A Category III code can be 'graduated' to Category I status if sufficient evidence of safety, efficacy, and broad use accumulates—typically over roughly five years. If that threshold is never reached, the code is archived. A cross-reference is inserted in the Category III section to point users toward any newly created Category I replacement.

Why it matters

Using a Category III code when one exists is not optional. When a Category III code describes the service performed, coders must report that code rather than an unlisted-procedure code (e.g., 27299 or 29999). Filing an unlisted code instead strips payers and policymakers of the utilization data they need to make coverage decisions—and it increases the risk of claim denial or audit scrutiny because the payer cannot match the service to any known descriptor. On the reimbursement side, many commercial payers and Medicare contractors will not pay Category III codes at all without a specific local coverage determination (LCD) or written authorization, so understanding a payer's stance before scheduling an emerging-technology procedure is essential to avoiding an unexpected write-off. Orthopedic practices adopting technologies such as robotic-assisted surgery adjuncts, novel implant tracking methods, or cutting-edge biologics are most likely to encounter these codes, and a miscoded claim—or a missed Category III code entirely—can trigger compliance flags and delay or forfeit payment.

Common mistakes

Where people most often go wrong with this concept.

Source · Editorial brief grounded in cited references ↓

Reporting an unlisted-procedure code (e.g., 27299, 29999) when a valid Category III code already exists for the service—this is the single most common Category III error and eliminates utilization tracking.
Assuming a Category III code is immediately billable on its release date; codes released January 1 are not reportable until July 1, and codes released July 1 are not reportable until the following January 1.
Treating assignment of a Category III code as evidence that the procedure is experimental or excluded from coverage—the code signals only that the technology is new, not that it is ineffective or non-covered.
Skipping payer pre-authorization because the procedure has a valid CPT code; most payers require explicit coverage review before paying any Category III service.
Failing to check the AMA's semiannual early-release updates, which means newly approved codes may be missed for up to six months after their Panel approval.
Attempting to assign RVUs or use standard fee-schedule calculations for Category III codes; no RVUs exist for these codes and payment is payer-specific.

Frequently asked questions

Source · Generated from the editorial pipeline, verified against 7 cited references ↓

01Does a Category III code mean the procedure is considered experimental?

No. A Category III designation means only that the technology or service is new and data collection is still in progress. It does not imply the procedure is unsafe, ineffective, or automatically excluded from coverage. Some payers will cover Category III services when medical necessity is established; others will not. Always verify payer policy before the procedure.

02When can I use an unlisted code instead of a Category III code?

Only when no Category III code accurately describes the service performed. If a Category III code exists that matches the procedure, that code must be reported. Using an unlisted code in place of an available Category III code is a coding error and can trigger claim denial or compliance review.

03How long does a Category III code stay active before it is archived?

Generally around five years. If the service has not accumulated enough evidence to support a Category I code by that point, the Category III code is typically archived. If it does graduate to Category I, a cross-reference is placed in the Category III section to direct users to the new permanent code.

04Are Category III codes paid by Medicare?

There is no national Medicare fee schedule for Category III codes because no RVUs are assigned. Payment depends on local Medicare Administrative Contractor (MAC) policy and any applicable Local Coverage Determination. Some MACs cover specific Category III codes; others do not. Check the relevant LCD before billing.

05How often does the AMA add new Category III codes?

The CPT Editorial Panel approves new Category III codes at its meetings and releases them twice a year—on January 1 and July 1—via the AMA's CPT website. Each batch has a six-month implementation window before it becomes reportable. The full updated set is also published in the annual CPT book.

06Which orthopedic procedures are most likely to require a Category III code?

Procedures involving robotic-assisted surgical adjuncts beyond what existing Category I codes cover, novel biologic injections or implants under investigational protocols, computer-navigation enhancements not already captured by standard codes, and certain augmented-reality or intraoperative imaging technologies are the most common orthopedic scenarios where a Category III code applies rather than a standard Category I code.

Sources & references

Editorial content was developed using the following public sources. Last verified May 8, 2026.

Mira AI Scribe

When Mira's documentation layer detects an operative note or procedure summary describing a service that lacks an obvious Category I CPT match—robotic guidance adjuncts, novel biologics, investigational implant systems, or other cutting-edge orthopedic technologies—it should flag the encounter for Category III code review before defaulting to an unlisted-procedure code. Mira should surface the relevant Category III candidate code(s) alongside a payer-coverage advisory noting that no RVUs are assigned, that payment depends on payer-specific policy or an applicable LCD, and that prior authorization may be required. If the AMA semiannual release has added or revised Category III descriptors within the past six months, Mira should prompt the coder to verify the implementation date before the code is submitted. Mira should never auto-select an unlisted code when a Category III code exists. Where the operative documentation supports a procedure that could qualify for either a Category III code or a newly graduated Category I code, Mira should present both options with a note explaining the distinction and the evidence threshold difference. Documentation recommendations should reinforce that the clinical record must support every element of the Category III descriptor—incomplete documentation is a primary driver of payer denials for these codes.

See Mira's approach

Related terms

CPT Category I Coding

CPT Category I codes are the main set of five-digit numeric codes published annually by the AMA to describe established medical and surgical procedures that are widely performed, FDA-cleared where required, and supported by peer-reviewed clinical evidence.

CPT Category II Coding

CPT Category II codes are optional, supplemental five-character alphanumeric codes (ending in 'F') used exclusively for performance measurement and quality data collection—they carry no reimbursement value and cannot substitute for Category I procedure codes.

Relative Value Unit (RVU) Reimbursement

A Relative Value Unit (RVU) is a numeric weight assigned to each CPT code that quantifies the resources required to perform a medical service; when multiplied by a conversion factor and geographic adjustments, it determines Medicare and commercial payer reimbursement.

Local Coverage Determination (LCD) Compliance

A Local Coverage Determination (LCD) is a regional Medicare policy issued by a Medicare Administrative Contractor (MAC) that defines when a specific service, procedure, or supply is considered reasonable and medically necessary within that contractor's jurisdiction.

HCPCS Level II Coding

HCPCS Level II is the CMS-maintained alphanumeric code set used to bill products, supplies, and services—such as DME, orthotics, prosthetics, and injectable drugs—that CPT codes do not adequately describe. Each code consists of one letter (A–V) followed by four digits.

Prior authorization Billing

Prior authorization (PA) is a payer requirement that a provider obtain approval before delivering a specific service, procedure, or item—otherwise the claim will be denied regardless of medical necessity. Approval is granted when submitted clinical documentation meets the payer's coverage criteria.